UNITY Biotechnology (UBX)
(Delayed Data from NSDQ)
$1.44 USD
+0.04 (2.86%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.43 -0.01 (-0.69%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for UNITY Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -39.86 | -59.93 | -60.73 | -93.84 | -82.18 |
Depreciation/Amortization & Depletion | 5.99 | 3.22 | 4.74 | 6.65 | 1.51 |
Net Change from Assets/Liabilities | -4.39 | -1.02 | -0.63 | -4.55 | 3.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.18 | 6.70 | 11.56 | 13.41 | 4.68 |
Net Cash From Operating Activities | -37.09 | -51.03 | -45.06 | -78.33 | -72.42 |
Property & Equipment | 0.10 | 0.28 | -0.20 | -0.65 | -1.59 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 60.39 | -24.83 | 39.51 | -4.56 | 69.54 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 60.50 | -24.55 | 39.31 | -5.21 | 67.95 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.50 | 0.14 | 2.13 | 2.09 | 1.43 |
Issuance (Repayment) of Debt | -20.00 | 0.00 | 0.14 | 24.88 | -0.07 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.84 | 54.71 | 18.57 | 36.91 | 26.09 |
Net Cash from Financing Activities | -16.34 | 54.86 | 20.85 | 63.88 | 27.44 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 7.07 | -20.72 | 15.10 | -19.67 | 22.97 |
Cash at Beginning of Period | 13.63 | 34.35 | 19.25 | 38.92 | 15.95 |
Cash at End of Period | 20.70 | 13.63 | 34.35 | 19.25 | 38.92 |
Diluted Net EPS | -2.70 | -6.31 | -10.90 | -18.40 | -18.80 |
Fiscal Year End for UNITY Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.07 | -5.79 | -39.86 | -38.36 | -23.07 |
Depreciation/Amortization & Depletion | -0.03 | -0.03 | 5.99 | 6.06 | 0.47 |
Net Change from Assets/Liabilities | 2.21 | 0.94 | -4.39 | -3.58 | -3.89 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -0.88 | -0.30 | 1.18 | 6.37 | 4.09 |
Net Cash From Operating Activities | -9.77 | -5.18 | -37.09 | -29.51 | -22.40 |
Property & Equipment | 0.02 | 0.02 | 0.10 | -0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -2.54 | -7.21 | 60.39 | 45.39 | 31.13 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -2.52 | -7.19 | 60.50 | 45.38 | 31.13 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.07 | 0.00 | 4.50 | 0.09 | 0.09 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -20.00 | -20.00 | -3.23 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.84 | -0.82 | 0.79 |
Net Cash from Financing Activities | 0.07 | 0.00 | -16.34 | -20.73 | -2.35 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -12.22 | -12.37 | 7.07 | -4.86 | 6.38 |
Cash at Beginning of Period | 20.70 | 20.70 | 13.63 | 13.63 | 13.63 |
Cash at End of Period | 8.48 | 8.33 | 20.70 | 8.77 | 20.01 |
Diluted Net EPS | -0.31 | -0.34 | -0.04 | -1.05 | -0.85 |